drug

Folic Acid

folic acid
MeSH D005492
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DIETARY_SUPPLEMENT
Pre-approval / investigational in the US
Developed by Capital Medical University
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DIETARY_SUPPLEMENT

Indications

Trials

3
Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects
NCT00815854—Completed
Evaluation of Mirtazapine and Folic Acid for Schizophrenia:
NCT01263080Phase 4Completed
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
NCT00611806Phase 4Completed

KOLs & investigators

3
Donald C. Goff, MDKOL score 8
Gang Wang, M.D.KOL score 5
Vicki L. Ellingrod, PharmD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Capital Medical University
company
trial
Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects
NA
trial
Evaluation of Mirtazapine and Folic Acid for Schizophrenia:
PHASE4
trial
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Insulin Resistance
indication
Metabolic Syndrome
indication
KOL
Donald C. Goff, MD
KOL score 8
person
Gang Wang, M.D.
KOL score 5
person
Vicki L. Ellingrod, PharmD
KOL score —
person